Spotlight
Money Desk
Obituaries
Classifieds
Families First
News
Weather
Specialists
Sports
Business
Opinion
Consumer
Health
Life
Out & About
Login
Weather
Wake County is under alert.
Program
On WRAL at 11: Storms rolling through Sunday night. We'll tell you if they'll affect your Labor Day plans in the morning
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Novartis Ag ADR
(NY:
NVS
)
120.89
+0.47 (+0.39%)
Official Closing Price
Updated: 7:00 PM EDT, Aug 30, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Novartis Ag ADR
< Previous
1
2
...
22
23
24
25
26
27
28
29
Next >
Novartis: Q3 Earnings Insights
October 26, 2021
Novartis (NYSE:NVS) reported its Q3 earnings results on Tuesday, October 26, 2021 at 08:00 AM. Here's what investors need to know about the announcement. Earnings...
Via
Benzinga
The Daily Biotech Pulse: Moderna Gains On Vaccine News, Novartis Reports Q3 Beat, Adcom Reviews Authorization Of Pfizer-BioNTech's Vaccine For Children
October 26, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Anaptys Sells Royalties Due On Cancer Drug Jemperli To Sagard For $250M...
Via
Benzinga
Novartis Mulls Strategic Options For Sandoz, Reaffirms FY21 Outlook
October 26, 2021
Novartis AG (NYSE: NVS) reported that its Q3 net income climbed 43% to $2.76 billion. EPS reached $1.23, up 45% Y/Y. Earnings: The Company posted a core EPS of $1.71,...
Via
Benzinga
Earnings Scheduled For October 26, 2021
October 26, 2021
Companies Reporting Before The Bell • Veoneer (NYSE:VNE) is likely to report quarterly loss at $0.83 per share on revenue of $408.69 million. • Aarons (NYSE:AAN)...
Via
Benzinga
Cyber Currency
October 26, 2021
Canadian stocks are particularly buoyant and not just in energy which is a riser today because the loony is up against the buck.
Via
Talk Markets
A Preview Of Novartis's Earnings
October 25, 2021
Novartis (NYSE:NVS) is set to give its latest quarterly earnings report on Tuesday, 2021-10-26. Here's what investors need to know before the announcement. Analysts estimate that...
Via
Benzinga
Price To Earnings Ratio Insights For Novartis
October 22, 2021
In the current market session, Novartis Inc. (NYSE:NVS) is trading at $84.51, after a 0.19% decrease. However, over the past month, the stock increased by 1.91%, and...
Via
Benzinga
Novartis Extends Fill/Finish Support For Pfizer/BioNTech COVID-19 Vaccines
October 21, 2021
Novartis AG (NYSE: NVS) has agreed to expand its fill-and-finish support for Pfizer Inc (NYSE: PFE) / BioNTech SE (NASDAQ: BNTX) COVID-19...
Via
Benzinga
Exposures
COVID-19
Wednesday Market Coverage
October 20, 2021
Today gold rose again despite the active market for bitcoin and the lower Chinese demand for mine products like iron and coal.
Via
Talk Markets
The Daily Biotech Pulse: Entasis, Dermata Spike Higher On Positive Readouts, J&J Q3 EPS Beats Estimates, Wave Life Sciences Regains Right To CNS Portfolio
October 19, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Entasis Announces Positive Data For Late-Stage Study Of SUL-DUR In...
Via
Benzinga
Great Place to Work® Announces the World’s Best Workplaces™ 2021
October 19, 2021
Great Place to Work® Announces the World’s Best Workplaces™ 2021
Via
News Direct
This Company Revolutionizes What Matters for Hospitals, Big Pharma and Health Insurers
October 14, 2021
You can perch on a 1-legged stool and balance precariously on 2, but if you want to settle in with comfort and safety, you need 3 sturdy legs. With its secure, cloud-based...
Via
Benzinga
3 No-Brainer Stocks to Buy Right Now
October 14, 2021
These stocks are all trading near their 52-week lows, but they're all solid investments to hold over the long term.
Via
The Motley Fool
Will Crispr Stock — And Its Cancer Drug — Rise After Allogene's Massive Fall?
October 12, 2021
Crispr is planning to begin a registrational test in the first quarter of 2022.
Via
Investor's Business Daily
eFFECTOR Therapeutics Stock Gains On Encouraging Preclinical Zotatifin Data In Breast Cancer
October 08, 2021
eFFECTOR Therapeutics Inc (NASDAQ: EFTR), in collaboration with Baylor College of Medicine, announced the presentation of new positive data for zotatifin in...
Via
Benzinga
Cannabis Movers & Shakers: TOCC, 1933 Industries, Iter Investments, Greenlane
October 06, 2021
Former Tilray Exec Steven Yoo Named Texas Original Compassionate Cultivation's New CFO Texas medical cannabis provider,&n...
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
September Update: The Conservative Pot Stocks Index Continued To Outperform
October 03, 2021
Reticent about investing in the seed-to-sale sector? Perhaps you should consider investing in more conservative cannabis-related companies, which have lost less YTD.
Via
Talk Markets
Topics
Cannabis
Exposures
Cannabis
Death Cross Looms Over Novartis Investors
September 30, 2021
If history is any guide, there may be trouble ahead for shares of Novartis(NYSE:NVS). A so-called "death cross" has formed on its chart and, not surprisingly, this could...
Via
Benzinga
A Bit Of A Recovery
September 29, 2021
While Germany remains without a government, Japan has a new prime minister who will lead his party in the election this week.
Via
Talk Markets
Novartis Posts New Data Reinforcing Efficacy, Convenience Of Cosentyx Autoinjector In Psoriasis
September 29, 2021
Novartis AG (NYSE: NVS) announced data from an international Phase 3b study of Cosentyx (secukinumab) in plaque psoriasis. Data showed that treatment with Cosentyx...
Via
Benzinga
This Potential Indication Could Be a Winner for Novartis
September 29, 2021
The U.S. Food and Drug Administration accepted Novartis' filing for tislelizumab to treat esophageal cancer.
Via
The Motley Fool
Exposures
Product Safety
Green Hygienics Holdings To Raise $100M Via Green Bond Offering
September 22, 2021
Hemp company Green Hygienics Holdings Inc. (OTCQB:GRYN) is ...
Via
Benzinga
A Day Of Huge Market Moves
September 21, 2021
It was a day of huge market moves and several reporting companies. Trudeau won but did not get a parliamentary majority.
Via
Talk Markets
Novartis Adds Vision Loss Gene Therapy Program Via Arctos Acquisition
September 21, 2021
Novartis AG (NYSE: NVS) has acquired Arctos Medical, adding a preclinical optogenetics-based AAV gene therapy program and Arctos’ proprietary technology to its...
Via
Benzinga
The Daily Biotech Pulse: Aprea Jumps On ESMO Presentation, Verrica Sinks On Regulatory Setback, Aerie CEO Quits, J&J Touts Positive COVID-19 Booster Shot Data
September 21, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 20) Cerevel Therapeutics...
Via
Benzinga
Exposures
COVID-19
Pharma, Tech and Finance
September 20, 2021
Good news on some drugs was not enough to boost stock markets.
Via
Talk Markets
Why Did Deutsche Bank Downgrade This Big Pharma Stock?
September 20, 2021
Deutsche Bank has downgraded Novartis AG (NYSE: NVS) to Sell from Hold with a price target of CHF 70, down from CHF 80. Analyst Emmanuel...
Via
Benzinga
Novartis' Kisqali Combo Therapy Extends Survival By One Year In Breast Cancer Patients
September 20, 2021
Novartis AG (NYSE: NVS) announced results of the final overall survival (OS) analysis of Phase 3 MONALEESA-2 study, which evaluated Kisqali (ribociclib) in...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 20, 2021
September 20, 2021
Upgrades For Methanex Corp (NASDAQ:
Via
Benzinga
The Week Ahead In Biotech (Sept. 19-25): Incyte, Verrica FDA Decisions And Conference Presentations In The Spotlight
September 19, 2021
Biotech stocks declined for the week ending Sept. 17, extending the losses from the previous week. European Society for Medical Oncology presentations, vaccine news, clinical...
Via
Benzinga
Exposures
Product Safety
< Previous
1
2
...
22
23
24
25
26
27
28
29
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.